| Secondary |
| Drug Use For Unknown Indication |
29.2% |
| Product Used For Unknown Indication |
26.0% |
| Immunisation |
7.8% |
| Tuberculosis |
6.6% |
| Tuberculin Test |
5.6% |
| Hiv Infection |
4.7% |
| Hepatitis C |
2.5% |
| Multiple Myeloma |
2.2% |
| Blood Pressure Increased |
1.6% |
| Depression |
1.6% |
| Hepatitis A |
1.6% |
| Hepatitis B |
1.6% |
| Prophylaxis |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Nausea |
1.3% |
| Schizophrenia, Residual Type |
1.3% |
| Atrial Fibrillation |
0.9% |
| Hepatitis B Immunisation |
0.9% |
| Human Immunodeficiency Virus Transmission |
0.9% |
| Antiviral Prophylaxis |
0.6% |
|
| Viral Infection |
23.5% |
| Vision Blurred |
9.8% |
| Limb Reduction Defect |
7.8% |
| Rash |
7.8% |
| Somnolence |
5.9% |
| Abortion Spontaneous |
3.9% |
| Coronary Artery Thrombosis |
3.9% |
| Drug Hypersensitivity |
3.9% |
| Maternal Drugs Affecting Foetus |
3.9% |
| Myocardial Infarction |
3.9% |
| Pyrexia |
3.9% |
| Tachycardia |
3.9% |
| Tourette's Disorder |
3.9% |
| Antibody Test Abnormal |
2.0% |
| Brain Oedema |
2.0% |
| Immune Reconstitution Syndrome |
2.0% |
| Leukocytoclastic Vasculitis |
2.0% |
| Liver Function Test Abnormal |
2.0% |
| Mental Status Changes |
2.0% |
| Myocarditis |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
39.1% |
| Product Used For Unknown Indication |
11.4% |
| Hypertension |
9.2% |
| Immunisation |
4.6% |
| Prophylaxis |
4.4% |
| Renal Failure |
3.7% |
| Rheumatoid Arthritis |
2.5% |
| Peritoneal Dialysis |
2.4% |
| Anaemia |
2.2% |
| Multiple Myeloma |
2.1% |
| Iron Deficiency |
2.0% |
| Vitamin Supplementation |
2.0% |
| Analgesia |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Blood Folate Decreased |
1.8% |
| Blood Phosphorus Increased |
1.8% |
| Gastritis |
1.8% |
| Hyperparathyroidism |
1.8% |
| Serum Ferritin Decreased |
1.8% |
| Respiratory Distress |
1.6% |
|
| Weight Decreased |
11.8% |
| Therapeutic Response Decreased |
9.8% |
| Vomiting |
8.8% |
| Transplant Rejection |
7.8% |
| Viral Pharyngitis |
7.8% |
| Application Site Vesicles |
5.9% |
| Nausea |
5.9% |
| Respiratory Distress |
5.9% |
| Weight Increased |
5.9% |
| Cyanosis |
4.9% |
| Hypoglycaemia |
3.9% |
| Maternal Exposure During Pregnancy |
3.9% |
| Muscle Spasms |
3.9% |
| Dermatitis Diaper |
2.0% |
| Diarrhoea |
2.0% |
| Gamma-glutamyltransferase Increased |
2.0% |
| Headache |
2.0% |
| Hypertension |
2.0% |
| Injection Site Urticaria |
2.0% |
| Ocular Hyperaemia |
2.0% |
|
